Hans-Jochem Kolb

发表

A. Barrett, D. Schendel, H. Kolb, 2003 .

Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia. The German CML Study Group.

H. Heimpel, J. Hasford, M. Horowitz, 1998, Blood.

Randomized Comparison of Imatinib 400 Mg Vs. Imatinib + IFN Vs. Imatinib + AraC Vs. Imatinib after IFN Vs. Imatinib 800 Mg: Optimized Treatment and Survival. Designed First Interim Analysis of the German CML Study IV

Martin C. Müller, H. Heimpel, J. Hasford, 2008 .

Prospective evaluation of neurological complications after allogeneic bone marrow transplantation

A. Straube, T. Yousry, G. Ledderose, 2003, Neurology.

NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia Reaction.

J. Ritz, M. V. D. van den Brink, A. Barrett, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment

N. Schmitz, H. Heimpel, H. Döhner, 2015, Leukemia.